ID: ALA95922

Max Phase: Preclinical

Molecular Formula: C5H9NO5S

Molecular Weight: 195.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)ON(C(C)=O)S(C)(=O)=O

Standard InChI:  InChI=1S/C5H9NO5S/c1-4(7)6(11-5(2)8)12(3,9)10/h1-3H3

Standard InChI Key:  RJFQQCBLTFTAMI-UHFFFAOYSA-N

Associated Targets(non-human)

Aldehyde dehydrogenase 1A1 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.20Molecular Weight (Monoisotopic): 195.0201AlogP: -0.73#Rotatable Bonds: 1
Polar Surface Area: 80.75Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -1.41CX LogD: -1.41
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.52Np Likeness Score: -0.43

References

1. Conway TT, DeMaster EG, Lee MJ, Nagasawa HT..  (1998)  Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.,  41  (15): [PMID:9667978] [10.1021/jm980200+]

Source